Q8Q3H0 (Q8Q3H0_9HIV1) Human immunodeficiency virus 1
Pol protein UniProtKBInterProInteractive Modelling
99 aa; Sequence (Fasta) ;
14 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
30 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal Structure of HIV-1 Protease (Q7K) in Complex with Lopinavir |
Heteromer P03367; Q5RZ08; | 4×CL; 1×AB1; 2×GOL; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Protease (Q7K) in Complex with Atazanavir |
Heteromer P03367; Q903J0; | 1×CL; 1×DR7; | ||||
| Assess | ||||||
| Crystal Structure of the subtype B wild type HIV protease complexed with TL-3 inhibitor |
Heteromer Q9Q288; Q9Q2G8; | 1×3TL; | ||||
| Assess | ||||||
| X-ray crystal structure of bPI-11 hiv-1 protease complex | homo-2-mer | 3×GOL; 2×SO4; 1×B0F; 1×CL; | ||||
| Assess | ||||||
| HIV-1 protease (D25N, inactive) in complex with phage display optimized substrate SGIFLETS | homo-2-mer | 4×CL; | ||||
| Assess | ||||||
| HIV-1 wild type protease with GRL-03314A, 6-5-5-ring fused umbrella-like tetrahydropyranofuran as t… | homo-2-mer | 1×GR8; 1×NA; 3×CL; 1×GOL; 2×ACT; | ||||
| Assess | ||||||
| HIV-1 wild type protease with GRL-03119A, with phenyl-boronic-acid as P2'-ligand and with a hexahyd… | homo-2-mer | 1×B4R; 1×NA; 5×CL; 1×FMT; 1×GOL; | ||||
| Assess | ||||||
| HIV-1 wild type protease with GRL-03214A, 6-5-5-ring fused umbrella-like tetrahydropyranofuran as t… | homo-2-mer | 1×NA; 2×CL; 2×GOL; 1×GR5; 1×ACT; | ||||
| Assess | ||||||
| HIV-1 wild type protease with GRL-00819A, with phenyl-boronic-acid as P2'-ligand and with a 6-5-5-r… | homo-2-mer | 1×NA; 4×CL; 1×FMT; 1×GOL; 1×Q1D; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I) in Complex with KNI-10033 | homo-2-mer | 1×O33; 1×GOL; | ||||
| Assess | ||||||
| HIV-1 protease I84V, L90M with TMC126 | homo-2-mer | 1×DJR; | ||||
| Assess | ||||||
| Crystal structure of WT HIV-1 protease with GS-8373 | homo-2-mer | 1×QFI; | ||||
| Assess | ||||||
| HIV-1 protease WT with GS-8374 | homo-2-mer | 1×KGQ; | ||||
| Assess | ||||||
| HIV-1 Protease I84V, L90M with GS-8374 | homo-2-mer | 1×KGQ; | ||||
| Assess | ||||||
| P1' Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimi… | homo-2-mer | 1×4AH; | ||||
| Assess | ||||||
| Stereoselective Synthesis, X-ray Analysis, and Biological Evaluation of a New Class of Lactam Based… | homo-2-mer | 1×UX9; | ||||
| Assess | ||||||
| INFLUENCE OF STEREOCHEMISTRY ON ACTIVITY AND BINDING MODES FOR C2 SYMMETRY-BASED DIOL INHIBITORS OF… | homo-2-mer | 1×A77; | ||||
| Assess | ||||||
| P1' Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimi… | homo-2-mer | 1×2AH; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Protease (Q7K) in Complex with Tipranavir | homo-2-mer | 1×TPV; 1×GOL; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 Protease (Q7K, L33I, L63I ) in Complex with KNI-10075 | homo-2-mer | 1×075; 1×GOL; | ||||
| Assess | ||||||
| Synthesis and Activity of N-Axyl Azacyclic Urea HIV-1 Protease Inhibitors with High Potency Against… | homo-2-mer | 1×AAU; | ||||
| Assess | ||||||
| HIV-1 protease in complex with asymmetric inhibitor, BEA568 | homo-2-mer | 1×568; | ||||
| Assess | ||||||
| HIV-1 protease in complex with symmetric inhibitor, BEA450 | homo-2-mer | 1×BLL; | ||||
| Assess | ||||||
| HIV Protease with inhibitor AB-2 | homo-2-mer | 2×AB2; | ||||
| Assess | ||||||
| VIRACEPT (R) (NELFINAVIR MESYLATE, AG1343): A POTENT ORALLY BIOAVAILABLE INHIBITOR OF HIV-1 PROTEASE | homo-2-mer | 1×1UN; | ||||
| Assess | ||||||
| HIV-1 protease in complex with inhibitor AHA455 | homo-2-mer | 1×A1A; | ||||
| Assess | ||||||
| P1' Extended HIV-1 Protease Inhibitors Encompassing a Tertiary Alcohol in the Transition-State Mimi… | homo-2-mer | 1×1AH; | ||||
| Assess | ||||||
| ALTERNATE BINDING SITE FOR THE P1-P3 GROUP OF A CLASS OF POTENT HIV-1 PROTEASE INHIBITORS AS A RESU… | homo-2-mer | 1×L75; | ||||
| Assess | ||||||
| Crystal structure of HIV-1 protease complexed with Lopinavir. | homo-2-mer | 1×AB1; | ||||
| Assess | ||||||
| The Influence of I47A Mutation on Reduced Susceptibility to the Protease Inhibitor Lopinavir | homo-2-mer | 2×BME; 1×AB1; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4f74.1.A | homo-2-mer | 0.85 | 1×SER; | 93.94 | ||
| Assess | ||||||